Literature DB >> 12738659

Activation of coagulation by administration of recombinant factor VIIa elicits interleukin 6 (IL-6) and IL-8 release in healthy human subjects.

Evert de Jonge1, Philip W Friederich, George P Vlasuk, William E Rote, Margaretha B Vroom, Marcel Levi, Tom van der Poll.   

Abstract

The activation of coagulation has been shown to contribute to proinflammatory responses in animal and in vitro experiments. Here we report that the activation of coagulation in healthy human subjects by the administration of recombinant factor VIIa also elicits a small but significant increase in the concentrations of interleukin 6 (IL-6) and IL-8 in plasma. This increase was absent when the subjects were pretreated with recombinant nematode anticoagulant protein c2, the inhibitor of tissue factor-factor VIIa.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12738659      PMCID: PMC154959          DOI: 10.1128/cdli.10.3.495-497.2003

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  22 in total

1.  Recombinant human antithrombin III improves survival and attenuates inflammatory responses in baboons lethally challenged with Escherichia coli.

Authors:  M C Minnema; A C Chang; P M Jansen; Y T Lubbers; B M Pratt; B G Whittaker; F B Taylor; C E Hack; B Friedman
Journal:  Blood       Date:  2000-02-15       Impact factor: 22.113

2.  Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin.

Authors:  M L Kahn; M Nakanishi-Matsui; M J Shapiro; H Ishihara; S R Coughlin
Journal:  J Clin Invest       Date:  1999-03       Impact factor: 14.808

3.  Ability of recombinant factor VIIa to generate thrombin during inhibition of tissue factor in human subjects.

Authors:  P W Friederich; M Levi; K A Bauer; G P Vlasuk; W E Rote; D Breederveld; T Keller; M Spataro; S Barzegar; H R Büller
Journal:  Circulation       Date:  2001-05-29       Impact factor: 29.690

4.  Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa.

Authors:  E Camerer; W Huang; S R Coughlin
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

5.  Thrombin and factor Xa enhance the production of interleukin-1.

Authors:  A Jones; C L Geczy
Journal:  Immunology       Date:  1990-10       Impact factor: 7.397

6.  Role of zymogen and activated factor X as scaffolds for the inhibition of the blood coagulation factor VIIa-tissue factor complex by recombinant nematode anticoagulant protein c2.

Authors:  P W Bergum; A Cruikshank; S L Maki; C R Kelly; W Ruf; G P Vlasuk
Journal:  J Biol Chem       Date:  2001-01-03       Impact factor: 5.157

7.  Tissue factor and factor VIIa receptor/ligand interactions induce proinflammatory effects in macrophages.

Authors:  M A Cunningham; P Romas; P Hutchinson; S R Holdsworth; P G Tipping
Journal:  Blood       Date:  1999-11-15       Impact factor: 22.113

8.  Tissue factor pathway inhibitor dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxemia.

Authors:  E de Jonge; P E Dekkers; A A Creasey; C E Hack; S K Paulson; A Karim; J Kesecioglu; M Levi; S J van Deventer; T van Der Poll
Journal:  Blood       Date:  2000-02-15       Impact factor: 22.113

9.  E-selectin and intercellular adhesion molecule-1 are released by activated human endothelial cells in vitro.

Authors:  J F Leeuwenberg; E F Smeets; J J Neefjes; M A Shaffer; T Cinek; T M Jeunhomme; T J Ahern; W A Buurman
Journal:  Immunology       Date:  1992-12       Impact factor: 7.397

10.  Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock.

Authors:  A A Creasey; A C Chang; L Feigen; T C Wün; F B Taylor; L B Hinshaw
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

View more
  21 in total

1.  Tissue factor in predicted severe acute pancreatitis.

Authors:  Ellen Andersson; Jakob Axelsson; Gunilla Eckerwall; Daniel Ansari; Roland Andersson
Journal:  World J Gastroenterol       Date:  2010-12-28       Impact factor: 5.742

2.  Association of ACE and FACTOR VII gene variability with the risk of coronary heart disease in north Indian population.

Authors:  R C Sobti; Nishi Maithil; Hitender Thakur; Yashpaul Sharma; K K Talwar
Journal:  Mol Cell Biochem       Date:  2010-04-03       Impact factor: 3.396

Review 3.  Disseminated intravascular coagulation: a review for the internist.

Authors:  Marcel Levi; Tom van der Poll
Journal:  Intern Emerg Med       Date:  2012-09-27       Impact factor: 3.397

Review 4.  Structure-Function Relationship of the Interaction between Tissue Factor and Factor VIIa.

Authors:  Joshua M Gajsiewicz; James H Morrissey
Journal:  Semin Thromb Hemost       Date:  2015-09-26       Impact factor: 4.180

Review 5.  Blood coagulation, inflammation, and malaria.

Authors:  Ivo M B Francischetti; Karl B Seydel; Robson Q Monteiro
Journal:  Microcirculation       Date:  2008-02       Impact factor: 2.628

6.  Sepsis-Associated Coagulopathy.

Authors:  Ecaterina Scarlatescu; Dana Tomescu; Sorin Stefan Arama
Journal:  J Crit Care Med (Targu Mures)       Date:  2016-11-08

7.  Mycobacterium tuberculosis infection and tissue factor expression in macrophages.

Authors:  Hema Kothari; L Vijaya Mohan Rao; Ramakrishna Vankayalapati; Usha R Pendurthi
Journal:  PLoS One       Date:  2012-09-24       Impact factor: 3.240

8.  Tissue factor, blood coagulation, and beyond: an overview.

Authors:  Arthur J Chu
Journal:  Int J Inflam       Date:  2011-09-20

Review 9.  Interplay between interleukin-6 signaling and the vascular endothelium in cytokine storms.

Authors:  Sujin Kang; Tadamitsu Kishimoto
Journal:  Exp Mol Med       Date:  2021-07-12       Impact factor: 12.153

Review 10.  The Impact of the Renin-Angiotensin-Aldosterone System on Inflammation, Coagulation, and Atherothrombotic Complications, and to Aggravated COVID-19.

Authors:  M Ekholm; T Kahan
Journal:  Front Pharmacol       Date:  2021-06-17       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.